 | Ipsen S.A. 2019 Q4 - Results - Earnings Call Presentation
seekingalpha.com - February 13 at 12:18 PM |
 | Ipsen Presents Its 2019 Results, Provides 2020 Guidance and Updates 2022 Financial Outlook
finance.yahoo.com - February 13 at 1:08 AM |
 | Credit Suisse Group Upgrades IPSEN S A/S (OTCMKTS:IPSEY) to "Neutral"
www.americanbankingnews.com - February 11 at 7:55 AM |
| IPSEN S A/S (IPSEY) Scheduled to Post Quarterly Earnings on Thursday
www.americanbankingnews.com - February 6 at 2:59 AM |
| IPSEN S A/S (OTCMKTS:IPSEY) Receives Average Recommendation of "Hold" from Brokerages
www.americanbankingnews.com - February 3 at 6:36 AM |
 | Peptide Therapeutics Market 2020 Size, Statistics, Growth, Revenue, Analysis & Trends Industry Forecast Report -2025|Market Research Engine
www.marketwatch.com - January 30 at 9:31 AM |
| Ipsen up 4% on diminished generic threat to Somatuline
seekingalpha.com - January 29 at 12:47 PM |
 | LIVE MARKETS-Opening snapshot: drug trials knock out Ipsen and HK drags Remy
www.lse.co.uk - January 25 at 1:36 PM |
| Ipsen hits potential roadblock with palovarotene
seekingalpha.com - January 25 at 1:36 PM |
| Ipsen’s palovarotene clinical program in fibrodysplasia ossificans progressiva reaches prespecified interim analysis futility criteria
finance.yahoo.com - January 24 at 5:16 AM |
| Ipsen Appoints Steven Hildemann, MD., PhD as Executive Vice President, Chief Medical Officer
finance.yahoo.com - January 14 at 1:15 AM |
| Ipsen: Dysport® (clostridium botulinum type A toxin-haemagglutinin complex) now approved in the UK for symptomatic treatment of upper limb spasticity in children with cerebral palsy
finance.yahoo.com - January 6 at 1:47 AM |
| Is Ipsen S.A. (EPA:IPN) Overpaying Its CEO?
finance.yahoo.com - January 3 at 4:36 PM |
| Ipsen Announces Its Corporate Agenda For 2020
finance.yahoo.com - December 19 at 1:35 PM |
 | Ipsen's CEO Resigns, to Join Ferring Unit
www.nytimes.com - December 18 at 8:16 AM |
| Ipsen Announces Departure of David Meek as Chief Executive Officer
finance.yahoo.com - December 18 at 8:16 AM |
| Ipsen: Monthly Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company
finance.yahoo.com - December 12 at 2:12 PM |
| FDA places partial clinical hold on studies of Ipsen's palovarotene
seekingalpha.com - December 6 at 12:22 PM |
| Ipsen Plunges as FDA Halts Bone Drug Trial in Children on Safety Concerns
finance.yahoo.com - December 6 at 12:22 PM |
| Ipsen Initiates Partial Clinical Hold for Palovarotene IND120181 and IND135403 Studies
finance.yahoo.com - December 6 at 1:36 AM |
| Does Ipsen S.A. (EPA:IPN) Have A Place In Your Dividend Portfolio?
finance.yahoo.com - December 4 at 7:25 AM |
| Health Canada approves CABOMETYX™ (cabozantinib) Giving Physicians and Adult Patients a New Second-Line Option in the Fight Against Advanced Hepatocellular Carcinoma
finance.yahoo.com - November 12 at 9:15 AM |
| Do Ipsen's (EPA:IPN) Earnings Warrant Your Attention?
finance.yahoo.com - November 6 at 9:02 AM |
| Ipsen Appoints Howard Mayer, M.D. as Executive Vice President and Head of Research and Development
finance.yahoo.com - November 5 at 8:07 AM |
| Proposed reclassification of Ipsen shares held by Mayroy
finance.yahoo.com - November 5 at 12:01 AM |
| Ipsen S.A. 2019 Q3 - Results - Earnings Call Presentation
seekingalpha.com - October 24 at 12:48 PM |
| Ipsen and Blueprint Medicines Announce Exclusive Global License Agreement to Develop and Commercialize BLU-782 for the Treatment of Fibrodysplasia Ossificans Progressiva (FOP)
finance.yahoo.com - October 16 at 7:20 AM |
| Health Canada approves Ipsen's Cabometyx for aRCC treatment
seekingalpha.com - October 15 at 2:22 PM |
| Should We Be Delighted With Ipsen S.A.'s (EPA:IPN) ROE Of 20%?
finance.yahoo.com - October 14 at 6:09 AM |
| FDA OKs expanded use of Ipsen's Dysport
seekingalpha.com - September 26 at 9:16 AM |
| Is Ipsen S.A.'s (EPA:IPN) P/E Ratio Really That Good?
finance.yahoo.com - September 24 at 8:02 AM |
| Ipsen's Dysport shows positive effect in post-market limb spasticity study
seekingalpha.com - September 23 at 5:00 PM |
| Ipsen to Present New Data at 13th Annual Conference of the International Liver Cancer Association (ILCA 2019)
finance.yahoo.com - September 21 at 3:28 PM |
| Ipsen's Onivyde shows positive action in mid-stage lung cancer study
seekingalpha.com - September 9 at 2:03 PM |
| Estimating The Fair Value Of Ipsen S.A. (EPA:IPN)
finance.yahoo.com - September 6 at 12:58 PM |
| Ipsen (EPA:IPN) Has A Pretty Healthy Balance Sheet
finance.yahoo.com - August 20 at 9:15 AM |
| Ipsen S.A. (EPA:IPN): The Best Of Both Worlds
finance.yahoo.com - August 4 at 10:22 AM |
| Ipsen S.A. ADR (IPSEY) CEO David Meek on Q2 2019 Results - Earnings Call Transcript
seekingalpha.com - July 28 at 10:37 AM |
| Ipsen S.A. 2019 Q2 - Results - Earnings Call Slides
seekingalpha.com - July 25 at 12:54 PM |
| Ipsen S.A. (EPA:IPN): Will The Growth Last?
finance.yahoo.com - July 18 at 11:24 AM |
| Ipsen and Servier Announce Initial Phase 1/2 Clinical Data Evaluating Liposomal Irinotecan (ONIVYDE®) as an Investigational First-line Treatment for Metastatic Pancreatic Cancer at ESMO 21st World Congress on Gastrointestinal Cancer
finance.yahoo.com - July 5 at 10:35 AM |
| Is Ipsen S.A. (EPA:IPN) Excessively Paying Its CEO?
finance.yahoo.com - July 3 at 10:45 AM |
| FDA OKs new pre-filled syringe for Ipsen's Somatuline Depot
seekingalpha.com - June 24 at 6:41 PM |
| Ipsen Celebrates Opening of New Cambridge Headquarters with Day of Service
finance.yahoo.com - June 20 at 4:53 PM |
| How Much Of Ipsen S.A. (EPA:IPN) Do Institutions Own?
finance.yahoo.com - June 10 at 11:30 AM |
| Ipsen's Dysport granted a licence update in UK
seekingalpha.com - June 5 at 10:37 AM |
| Ipsen's Dysport® (Clostridium Botulinum Type a Toxin-haemagglutinin Complex) Becomes First and Only Botulinum Toxin Type A to be Granted a Licence Update for Administration by Healthcare Professionals, Such as Physiotherapists, in the UK
finance.yahoo.com - June 5 at 10:37 AM |
| KNDL 2019-KNSQ Mortgage Trust -- Moody's assigns definitive ratings to Five CMBS classes of KNDL 2019-KNSQ Mortgage Trust
finance.yahoo.com - May 30 at 4:55 PM |
| Does Ipsen (EPA:IPN) Deserve A Spot On Your Watchlist?
finance.yahoo.com - May 24 at 10:48 AM |
| Ipsen to Host an Investor Day to Highlight Its Innovative R&D Pipeline and Provide Financial Outlook for 2022
finance.yahoo.com - May 14 at 11:12 AM |
